The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus

Autor: Galarza-Maldonado, Claudio a, Kourilovitch, María R. a, b, Molineros, Julio E. c, Cardiel, Mario H. d, Zurita, Luis e, Soroka, Nikolay F. f, Yagur, Viktor Y. f, Doukh, Natalia g, Cervera, Ricard b, ⁎
Zdroj: In Autoimmunity Reviews 2010 10(2):108-111
Databáze: ScienceDirect